将阻塞性睡眠呼吸暂停成人转诊至外科会诊:美国睡眠医学会系统评价、荟萃分析和 GRADE 评估

2021-08-15 美国睡眠医学会 J Clin Sleep Med

该系统评价为随附的关于将阻塞性睡眠呼吸暂停 (OSA) 成人患者转诊至外科会诊的临床实践指南提供了支持证据。

中文标题:

将阻塞性睡眠呼吸暂停成人转诊至外科会诊:美国睡眠医学会系统评价、荟萃分析和 GRADE 评估

英文标题:

Referral of adults with obstructive sleep apnea for surgical consultation: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment

发布机构:

美国睡眠医学会

发布日期:

2021-08-15

简要介绍:

该系统评价为随附的关于将阻塞性睡眠呼吸暂停 (OSA) 成人患者转诊至外科会诊的临床实践指南提供了支持证据。

相关资料下载:
[AttachmentFileName(sort=1, fileName=将阻塞性睡眠呼吸暂停成人转诊至外科会诊:美国睡眠医学会系统评价、荟萃分析和 GRADE 评估.pdf)] GetToolGuiderByIdResponse(projectId=1, id=beeb71c002258e17, title=将阻塞性睡眠呼吸暂停成人转诊至外科会诊:美国睡眠医学会系统评价、荟萃分析和 GRADE 评估, enTitle=Referral of adults with obstructive sleep apnea for surgical consultation: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment, guiderFrom=J Clin Sleep Med, authorId=0, author=, summary=该系统评价为随附的关于将阻塞性睡眠呼吸暂停 (OSA) 成人患者转诊至外科会诊的临床实践指南提供了支持证据。, cover=https://img.medsci.cn/2021119/1636440632429_1608702.jpg, journalId=0, articlesId=null, associationId=38, associationName=美国睡眠医学会, associationIntro=美国睡眠医学会(AASM)学院设置睡眠医学保健,教育和出版实践参数,系统评价,临床指南及最佳实践指南的研究等领域的临床标准。每个指南是由独立的专家审查,所有文件至少每5年进行审查一次,并在必要时更新。, copyright=0, guiderPublishedTime=Sun Aug 15 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p>该系统评价为随附的关于将阻塞性睡眠呼吸暂停 (OSA) 成人患者转诊至外科会诊的临床实践指南提供了支持证据。</p>, tagList=[TagDto(tagId=3180, tagName=阻塞性睡眠呼吸暂停), TagDto(tagId=10035, tagName=睡眠呼吸障碍)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=30, categoryName=耳鼻咽喉科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=3180, guiderKeyword=阻塞性睡眠呼吸暂停, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=127506, appHits=136, showAppHits=0, pcHits=540, showPcHits=127369, likes=0, shares=13, comments=6, approvalStatus=1, publishedTime=Tue Nov 16 23:57:33 CST 2021, publishedTimeString=2021-08-15, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=5, createdBy=null, createdName=FUNNYMAN, createdTime=Tue Nov 09 15:46:04 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Sat Jan 06 22:51:30 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=将阻塞性睡眠呼吸暂停成人转诊至外科会诊:美国睡眠医学会系统评价、荟萃分析和 GRADE 评估.pdf)])
将阻塞性睡眠呼吸暂停成人转诊至外科会诊:美国睡眠医学会系统评价、荟萃分析和 GRADE 评估.pdf
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1183663, encodeId=61ef1183663c5, content=是中文版那, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5655619900, createdName=ms7000001658661498, createdTime=Wed Jan 12 21:22:56 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077432, encodeId=d5e910e74325a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78cf5534510, createdName=ms1000000803763382, createdTime=Mon Dec 06 18:26:13 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069898, encodeId=57c1106989839, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160227/IMG56D1989D087E64175.jpg, createdBy=d63e109303, createdName=qiuxiaoping, createdTime=Sat Nov 13 15:22:58 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068849, encodeId=75af1068849eb, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Nov 10 06:49:32 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068730, encodeId=2a361068e307c, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644b2182796, createdName=1207866fm50(暂无昵称), createdTime=Tue Nov 09 20:56:27 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2022-01-12 ms7000001658661498

    是中文版那

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1183663, encodeId=61ef1183663c5, content=是中文版那, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5655619900, createdName=ms7000001658661498, createdTime=Wed Jan 12 21:22:56 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077432, encodeId=d5e910e74325a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78cf5534510, createdName=ms1000000803763382, createdTime=Mon Dec 06 18:26:13 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069898, encodeId=57c1106989839, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160227/IMG56D1989D087E64175.jpg, createdBy=d63e109303, createdName=qiuxiaoping, createdTime=Sat Nov 13 15:22:58 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068849, encodeId=75af1068849eb, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Nov 10 06:49:32 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068730, encodeId=2a361068e307c, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644b2182796, createdName=1207866fm50(暂无昵称), createdTime=Tue Nov 09 20:56:27 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2021-12-06 ms1000000803763382

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1183663, encodeId=61ef1183663c5, content=是中文版那, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5655619900, createdName=ms7000001658661498, createdTime=Wed Jan 12 21:22:56 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077432, encodeId=d5e910e74325a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78cf5534510, createdName=ms1000000803763382, createdTime=Mon Dec 06 18:26:13 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069898, encodeId=57c1106989839, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160227/IMG56D1989D087E64175.jpg, createdBy=d63e109303, createdName=qiuxiaoping, createdTime=Sat Nov 13 15:22:58 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068849, encodeId=75af1068849eb, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Nov 10 06:49:32 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068730, encodeId=2a361068e307c, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644b2182796, createdName=1207866fm50(暂无昵称), createdTime=Tue Nov 09 20:56:27 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2021-11-13 qiuxiaoping

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1183663, encodeId=61ef1183663c5, content=是中文版那, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5655619900, createdName=ms7000001658661498, createdTime=Wed Jan 12 21:22:56 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077432, encodeId=d5e910e74325a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78cf5534510, createdName=ms1000000803763382, createdTime=Mon Dec 06 18:26:13 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069898, encodeId=57c1106989839, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160227/IMG56D1989D087E64175.jpg, createdBy=d63e109303, createdName=qiuxiaoping, createdTime=Sat Nov 13 15:22:58 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068849, encodeId=75af1068849eb, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Nov 10 06:49:32 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068730, encodeId=2a361068e307c, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644b2182796, createdName=1207866fm50(暂无昵称), createdTime=Tue Nov 09 20:56:27 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2021-11-10 微探

    学习学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1183663, encodeId=61ef1183663c5, content=是中文版那, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5655619900, createdName=ms7000001658661498, createdTime=Wed Jan 12 21:22:56 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077432, encodeId=d5e910e74325a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78cf5534510, createdName=ms1000000803763382, createdTime=Mon Dec 06 18:26:13 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069898, encodeId=57c1106989839, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160227/IMG56D1989D087E64175.jpg, createdBy=d63e109303, createdName=qiuxiaoping, createdTime=Sat Nov 13 15:22:58 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068849, encodeId=75af1068849eb, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Nov 10 06:49:32 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068730, encodeId=2a361068e307c, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644b2182796, createdName=1207866fm50(暂无昵称), createdTime=Tue Nov 09 20:56:27 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2021-11-09 1207866fm50(暂无昵称)

    谢谢分享

    0

拓展阅读

2010 阻塞性睡眠呼吸暂停与糖尿病专家共识

中华医学会呼吸病学分会 · 2010-05-01

2012 AAP儿童阻塞性睡眠呼吸暂停综合征的诊断与治疗指南

美国儿科学会(AAP,American Academy of Pediatrics) · 2012-08-27

2012 SAMBA共识:成人阻塞性睡眠呼吸暂停患者接受门诊手术的术前选择

门诊麻醉学会(SAMBA,The Society for Ambulatory Anesthesia) · 2012-11-01

2013 ERS/ESH 阻塞性睡眠呼吸暂停与高血压患者管理建议

欧洲呼吸学会(ERS,European Respiratory Society) · 2013-05-01